Paulson & Co. exits AngloGold Ashanti, boosts Madrigal Pharma among Q3 moves

0


bodnarchuk/iStock via Getty Images

  • Paulson & Co. exited its position in AngloGold Ashanti (NYSE:AU) in Q3, according to the fund’s latest 13F filing.
  • The fund increased its stake in Madrigal Pharmaceuticals.
  • Paulson & Co. also reduced its position in Altice USA (ATUS) in



LEAVE A REPLY

Please enter your comment!
Please enter your name here